Rennova Health Inc (NASDAQ:RNVA) closed its last session at $0.1638 with the change of +12.7323%. The market capitalization of the company is $6.94M with an average Volume of 1.8 million shares. The stock currently has its 52-Week High range of $6.4000 and 52-week low range of $0.1400. The stock traded total quantity of 6 million shares.
According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. Currently shares have been suggested as “BUY” from “1” brokerage firms and recommended as “Strong Buy” by “0” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “3” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 2.13 based on consensus of the brokerage firms issuing ratings.
The average true range of Rennova Health, Inc.’s (RNVA) is recorded at 0.02 and the relative strength index of the stock stands 34.45. The stock price is going above to its 52 week low with 17.00% and lagging behind from its 52 week high with -97.44%. Analyst recommendation for this stock stands at 3.00. A look on the firm performance, its monthly performance is -34.48% and a quarterly performance of -41.50%. The stock price is trading downbeat from its 200 days moving average with -71.34% and down from 50 days moving average with -30.21%.
ARRIS Group, Inc. (NASDAQ:ARRS) ended its last trade at $28.59 with the move of -0.10%. The company has market value of $5.45B with the total traded volume of 740.39 thousand. The stock currently has its 52-Week top value of $32.93 and 52-week down value of $20.05. The price to book (P/B) ratio of the company is 1.84. Its previous closing price was recorded at $28.62.
The stock has received ratings from many brokerage firms according to ZACKS. Currently shares have been rated as “Buy” from “0” brokerage firms and “3” brokerage firms say as “Strong Buy”. “0” brokerage firms have suggested “Sell” for the company. “0” brokerage firms have recommended as a “Hold”. Strong Sell rating was given by “1.43” brokerage firms. The Company has average brokerage recommendation (ABR) of “2.13” based on consensus of the ZACKS brokerage firms.
ARRIS International plc’s (ARRS) has price-to-cash ratio of 6.09 and price to sale ratio of 0.96. The company net profit margin is -1.10% and gross profit margin is 27.30%. A look on the firm performance, its monthly performance is 1.06% and a quarterly performance of 13.90%. The stock price is moving up from its 20 days moving average with 0.16% and isolated positively from 50 days moving average with 2.28%.